Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Bench International and Senscio Systems Partner to Redefine Patient-Empowered Healthcare
Bench International, a long-standing women-founded company that offers executive search, recruitment, and leadership advisory services, has announced a strategic partnership with Senscio Systems, an AI-based healthcare company that focuses on care for elderly people with multiple chronic conditions. This collaboration aims to align leadership and organizational strategies to support Senscio Systems’ national growth and to work together towards the goal of transforming healthcare by putting patients, especially seniors, at the heart of care. The partnership will help seniors manage their health at home through data-supported support, engagement, and education, which leads to better outcomes and lower costs for healthcare payers.
AMR Clinical Adopts SiteGrades for Smarter Operations
AMR Clinical, a well-known integrated research site organization with more than 30 locations throughout the United States, has chosen Todata Analytics’ SiteGrades as its enterprise operational intelligence platform. This partnership aims to improve capacity management, standardize how sites perform, and ensure that all locations operate consistently across AMR Clinical’s wide network. By bringing together data from existing systems, SiteGrades offers a clear picture of enrollment progress, how exam rooms are used, staff availability, and the financial performance of each site—without adding more data entry tasks. This central view gives leaders the ability to make quicker and more informed choices about how to manage resources, improve processes, and recruit participants across their database of over one million people.
Dialog Health’s AI Translator Brings 130+ Languages to Patient Text Messaging
Dialog Health, a well-known leader in healthcare communication solutions, has launched a new feature: an AI Translator that supports over 130 languages and allows for smooth two-way text messaging between healthcare providers, patients, and caregivers. This update lets organizations chat in the language patients prefer, helping to remove communication barriers that can affect the quality of care and patient results. In today’s world, speaking with patients in their preferred language builds trust, makes them more satisfied, helps meet regulations, and can improve both how well care is provided and how efficiently healthcare organizations operate. While many healthcare providers use translation services in person, expanding that support to mobile messaging has been hard because of limited resources and technical issues.
Wheeler Bio Partners with Mitsubishi for APAC Expansion
Wheeler Bio, a U.S.-based company that specializes in high science and high-touch contract development and biomanufacturing, has announced a strategic partnership with Mitsubishi Corporation. This partnership is meant to help Wheeler expand its presence and business development activities in the Asia-Pacific region. As part of this cooperation, Mitsubishi is investing in Wheeler’s Series A-1 financing. Mitsubishi will use its wide regional network, strong industry connections, and extensive commercial experience to help biotech companies in Japan, South Korea, India, Singapore, Taiwan, and China access U.S.-based development and cGMP manufacturing services. Mitsubishi has been named Wheeler’s exclusive partner in the region, and its focus will be on building new client relationships and helping biologics developers connect with Wheeler’s AI/ML-enabled ModularCMC platform and its advanced cGMP manufacturing facility in Oklahoma City. Wheeler Bio’s ModularCMC platform is designed to speed up the process of moving from discovery to clinical development for antibody-based therapies. It offers speed, flexibility, and scalability, along with a high-touch approach that is grounded in scientific rigor, transparency, and collaborative partnership.
CustoMED Raises $6 Million to Expand AI 3D Orthopedic Solutions
CustoMED, a top innovator in AI-powered tools for surgeons, has completed its seed funding round, raising a total of $6 million. This round includes investments from Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, a major orthopedic implant company, and Avishai Abrahami, co-founder and CEO of Wix. This funding will help the company grow and spread its technology around the world.
To share your insights, please write to us at tony@intentamplify.com
